Sinovac

All news and posts of our editorial team on the topic

Report: Delayed approval of BioNTech
Apparently, China wants to give preference to a self-developed mRNA vaccine instead of approving the German product from BioNTech. The Wall Street Journal quotes informed circles as saying that the approval procedure for the BioNTech preparation is currently deliberately delayed. The reason is concern about confidence in homegrown vaccines. Accelerated approval of the state-of-the-art ingredient […] continue reading →
China begins Corona vaccination of teenagers
Several areas in China will begin Corona vaccination of teenagers soon. The southwestern region of Guangxi and the city of Jingmen in the central province of Hubei will start vaccinating 15- to 17-year-olds before the end of July, Reuters reported Wednesday, citing state officials. Vaccination of children aged 12 to 14 will then begin in […] continue reading →
Covax receives Chinese vaccines
The two Chinese pharmaceutical companies Sinovac and Sinopharm will provide a total of 110 million doses of their Covid vaccines to the international vaccination initiative Covax in the coming months. The rollout of vaccines will begin immediately, according to vaccination alliance Gavi, which Covax jointly launched with the World Health Organization (WHO) and the research […] continue reading →
EU vaccine passport leaves choice of Chinese vaccine open
The European Union’s planned digital vaccination passport currently excludes Chinese vaccines from Sinopharm and Sinovac, but the EU is giving member states the freedom to decide whether to accept COVID-19 vaccines, which have not yet been approved by the European Medicines Agency (EMA). The EU Commission had unveiled the digital vaccination certificate, called “Digital Green […] continue reading →
Sinovac: doubts on Covid vaccine
The Chinese vaccine manufacturer Sinovac cannot credibly prove the initially assumed effectiveness of its Covid vaccine. This unsettles the population, especially in emerging countries that Sinovac wants to supply. continue reading →
Peru stops Sinopharm test
In the development of its Covid vaccine, Chinese manufacturer Sinopharm has suffered a setback. As reported by Deutsche Welle, Peru has suspended clinical tests of the company’s vaccine due to health problems in test subjects. The United Arab Emirates was the only country to have approved the Chinese vaccine in early December, the first time […] continue reading →